These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 16203650

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido.
    Oranratanaphan S, Taneepanichskul S.
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S17-22. PubMed ID: 17726807
    [Abstract] [Full Text] [Related]

  • 43. Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women.
    Giribela CR, Consolim-Colombo FM, Nisenbaum MG, Moraes TL, Giribela AH, Baracat EC, Melo NR.
    Gynecol Endocrinol; 2015 Oct; 31(11):912-5. PubMed ID: 26172927
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Comparative pharmacology of newer progestogens.
    Kuhl H.
    Drugs; 1996 Feb; 51(2):188-215. PubMed ID: 8808163
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat.
    Shirk RA, Zhang Z, Winneker RC.
    J Steroid Biochem Mol Biol; 2005 Mar; 94(4):361-8. PubMed ID: 15857755
    [Abstract] [Full Text] [Related]

  • 49. The pharmacology of nomegestrol acetate.
    Ruan X, Seeger H, Mueck AO.
    Maturitas; 2012 Apr; 71(4):345-53. PubMed ID: 22364709
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Drospirenone, a progestin with a unique cardiovascular profile, for safe contraception and treatment of menopausal symptoms.
    Ylikorkala O.
    Climacteric; 2005 Oct; 8 Suppl 3():1-3. PubMed ID: 16203649
    [No Abstract] [Full Text] [Related]

  • 52. Menopause and cardiovascular disease: the evidence.
    Rosano GM, Vitale C, Marazzi G, Volterrani M.
    Climacteric; 2007 Feb; 10 Suppl 1():19-24. PubMed ID: 17364594
    [Abstract] [Full Text] [Related]

  • 53. Potential role of progestogens in the control of adipose tissue and salt sensitivity via interaction with the mineralocorticoid receptor.
    Caprio M, Zennaro MC, Fève B, Mammi C, Fabbri A, Rosano G.
    Climacteric; 2008 Jun; 11(3):258-64. PubMed ID: 18568791
    [Abstract] [Full Text] [Related]

  • 54. Effect of an oral contraceptive containing 30 microg ethinylestradiol plus 3 mg drospirenone on body composition of young women affected by premenstrual syndrome with symptoms of water retention.
    Fruzzetti F, Lazzarini V, Ricci C, Quirici B, Gambacciani M, Paoletti AM, Genazzani AR.
    Contraception; 2007 Sep; 76(3):190-4. PubMed ID: 17707715
    [Abstract] [Full Text] [Related]

  • 55. Medroxyprogesterone acetate but not drospirenone ablates the protective function of 17 beta-estradiol in aldosterone salt-treated rats.
    Arias-Loza PA, Hu K, Schäfer A, Bauersachs J, Quaschning T, Galle J, Jazbutyte V, Neyses L, Ertl G, Fritzemeier KH, Hegele-Hartung C, Pelzer T.
    Hypertension; 2006 Nov; 48(5):994-1001. PubMed ID: 17000933
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.